Dec. 17, 2018 – Writing from Britain, Dr. Ben Goldacre echoes Angell’s concerns, charging in “Bad Pharma” that the worst misbehavior in the pharmaceutical industry actually occurs not when prescription drugs are being burnished for market, but far earlier in their development. Lackluster compounds are evaluated in ways guaranteed to make them look good, Goldacre writes, then prettied up even further with distorted claims of efficacy. While “bad behavior in marketing departments is unpleasant,” he concludes, the real scientific outrage and the big public danger lie in uniformly dubious practices of drug development.
GIVING BACK IN STYLE – April 17, 2024 - “It’s still one day at…
RIDING THE WAVE...CALMLY – April 18, 2024 - “I was 13 years old and…
VIDEO – NEW YORK STORIES – April 23, 2024 - Sara Gettelfinger had steadily…
TRY IT, YOU’LL LIKE IT – April 18, 2024 - The rise in “sober…
AUDIO – SOBER MEN CAN DO THAT – April 4, 2024 - Acting icon…
I’LL BET HE GOES TO GA (not Georgia) – April 13, 2024 -The initial…